Global Forum of the World Federation of Hemophilia, September 26–27, 2005, Montreal, Quebec, Canada
World Federation of Hemophilia
A. Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
Australian Therapeutic Goods Administration
Food and Drug Administration, United States
Manchester Royal Infirmary, United Kingdom
Human Plasma Product services, Lille, France
Canadian Blood Services
Natal BioProducts Institute, South Africa
University of Ottawa, Canada
Australian Therapeutic Goods Administration
National Institute for Biological Standards and Control, United Kingdom
Paul Ehrlich Institute, Germany
Centers for Disease Control and Prevention, United States
Plasma Protein Purification System
Bayer Healthcare, Biological Products, Canada
Food and Drug Administration, United States
Canadian Hemophilia Society
Irish Haemophilia Society
Plasma Proteins Therapeutics Association
Manchester Royal Infirmary, United Kingdom
Brazilian Ministry of Health
World Federation of Hemophilia
World Health Organization, Geneva
World Federation of Hemophilia
Received 23 June 2006; accepted 5 July 2006.
Contributors
PII: S1473-0502(06)00114-5
doi:10.1016/j.transci.2006.07.003